Login

Frédéric Gardès' Opening Speech at the Conference: 'Innovations for Smart Mobility | Frédéric Gardès - CEO of Colas Group 00:10:00

Share On Facebook Share On Twitter

Frédéric Gardès is the CEO of Colas Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
June 18 Quarter Economic Update: Reflecting on Success and Strategic Positioning | Justin Hyland, Managing Director, Hyland Financial Planning.
00:10:00
Essential Estate Planning Documents: A Guide from Taylor Financial | Adam Taylor, CEO, Taylor Financial.
00:10:00
Stefan Meister, Executive Chairman of Partners Group, Discusses the Role of Private Markets in a Recalibrating Economy
00:10:00
Crypto currency is a threat as well as a great chance also|Aubrie Pagano,General Partner,Alpaca VC
00:10:00
Boosted by strong performance, Baader Bank AG's stock is discussed alongside 7C Solarparken CEO Steven De Proost's insights on goals, growth, and directors' dealings in SdK Talk.
00:10:00
Chalice Gold: Exploring New Frontiers in Gold and Mineral Development - Insights from Director Tim Goitre Mani at the One-to-One Mining Conference
00:10:00
Cerillion plc larger quality orders in pipeline increasing revenues | Louis Hall, CEO, Cerillion PLCCER:LSE
00:10:00
Exploration Targets Major Gold Discovery in Prime Jurisdiction
00:10:00
Global Demand Trends in EV and ESS Sectors
00:10:00
Jean, CEO of Wellington: A Journey of Leadership and Legacy| Jean M. Hynes, CEO , Wellington Management Company.
00:10:00
Mats Rahmström: Leading Atlas Copco as President and CEO Since 2017 | Mats Rahmström, President, Atlas Copco Group.
00:10:00
A venture capital fund focused on early-stage companies in the positive living space|Amanda Eilian,Founding Partner,Able Partners

© 2017 - Neuhu+